Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP505198.RAx8N1d9dv6pnTqK3OBQcl6XTanJt1g5C4KHVlb6-uLz0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP505198.RAx8N1d9dv6pnTqK3OBQcl6XTanJt1g5C4KHVlb6-uLz0130_assertion type Assertion NP505198.RAx8N1d9dv6pnTqK3OBQcl6XTanJt1g5C4KHVlb6-uLz0130_head.
- NP505198.RAx8N1d9dv6pnTqK3OBQcl6XTanJt1g5C4KHVlb6-uLz0130_assertion description "[The impact of recombinant human growth hormone (rhGH) treatment on growth, bone mineral metabolism, and bone mineral density (BMD) was evaluated in six children (3 girls, 3 boys) with familial hypophosphatemic rickets (XLH).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP505198.RAx8N1d9dv6pnTqK3OBQcl6XTanJt1g5C4KHVlb6-uLz0130_provenance.
- NP505198.RAx8N1d9dv6pnTqK3OBQcl6XTanJt1g5C4KHVlb6-uLz0130_assertion evidence source_evidence_literature NP505198.RAx8N1d9dv6pnTqK3OBQcl6XTanJt1g5C4KHVlb6-uLz0130_provenance.
- NP505198.RAx8N1d9dv6pnTqK3OBQcl6XTanJt1g5C4KHVlb6-uLz0130_assertion SIO_000772 9323282 NP505198.RAx8N1d9dv6pnTqK3OBQcl6XTanJt1g5C4KHVlb6-uLz0130_provenance.
- NP505198.RAx8N1d9dv6pnTqK3OBQcl6XTanJt1g5C4KHVlb6-uLz0130_assertion wasDerivedFrom befree-20140225 NP505198.RAx8N1d9dv6pnTqK3OBQcl6XTanJt1g5C4KHVlb6-uLz0130_provenance.
- NP505198.RAx8N1d9dv6pnTqK3OBQcl6XTanJt1g5C4KHVlb6-uLz0130_assertion wasGeneratedBy ECO_0000203 NP505198.RAx8N1d9dv6pnTqK3OBQcl6XTanJt1g5C4KHVlb6-uLz0130_provenance.